4th quarter and preliminary year end financials for 2019 for Medistim ASA

4th quarter was the second best quarter ever and 2019 was record sales for a year. Sales for the quarter ended at MNOK 95.7 (MNOK 97.9), while sales for 2019 ended at MNOK 363.7 (MNOK 325.9), a growth of 11.6 %. Sales in USA increased with 20.3 % in 2019 while Europe had a strong 4th quarter with a 39.0 % growth in sales of own products.

Currency neutral sales of own products decreased with 6.8 % for the quarter. For 2019, currency neutral growth in sales of own products was 10.3%. EBIT for the quarter ended at MNOK 19.7 (MNOK 27.8). For 2019 EBIT ended at MNOK 89.8 (MNOK 74.0), a 21.3 % growth. Earnings per share ended at NOK 3.87 (NOK 3.14) a 23.3 % increase. The Board suggests a dividend of NOK 2.75 per share (NOK 2.25), a 22.2 % increase.